Commonwealth Equity Services’s Fulcrum Therapeutics FULC Stock Holding History

Commonwealth Equity Services’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$146K	Sell	40,000 -290	-0.7%	-$1.76K	﹤0.01%	4202
2026 Q1	$309K	Buy	40,290 +290	+0.7%	+$2.69K	﹤0.01%	3637
2025 Q4	$452K	Sell	40,000 -43,428	-52%	-$442K	﹤0.01%	3248
2025 Q3	$768K	Hold	83,428	–	–	﹤0.01%	2796
2025 Q2	$574K	Hold	83,428	–	–	﹤0.01%	3037
2025 Q1	$240K	Hold	83,428	–	–	﹤0.01%	3689
2024 Q4	$392K	Sell	83,428 -1,000	-1%	-$3.69K	﹤0.01%	3171
2024 Q3	$301K	Hold	84,428	–	–	﹤0.01%	3352
2024 Q2	$523K	Buy	84,428 +1,000	+1%	+$7.58K	﹤0.01%	2797
2024 Q1	$788K	Sell	83,428 -13,000	-13%	-$116K	﹤0.01%	2422
2023 Q4	$651K	Buy	+96,428	New	+$428K	﹤0.01%	2498

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth Equity Services's FULC Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Fulcrum Therapeutics (FULC) stake by 0.72% in Q2 2026, selling an estimated $1.76K and leaving 40,000 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #4202.

Commonwealth Equity Services first reported a position in FULC in Q4 2023 and has held it in 11 quarters since. The position peaked at $788K in Q1 2024. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

Commonwealth Equity Services held 40,000 shares of Fulcrum Therapeutics worth $146K as of Q2 2026.
Commonwealth Equity Services sold 290 Fulcrum Therapeutics shares in Q2 2026, an estimated $1.76K.
Fulcrum Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4202 holding.
Commonwealth Equity Services first reported a position in Fulcrum Therapeutics in Q4 2023 and has held it in 11 quarters since.
Commonwealth Equity Services's Fulcrum Therapeutics position peaked at $788K in Q1 2024.
155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.